DV
Dividend Vision

ADCT — ADC Therapeutics SA

ADC Therapeutics SA (ADCT)

Total return is -96.6% over the past 6.2 years, 292.4 points behind SPY at 195.8%. Its deepest 1-year drawdown was 80.0%.

ADCT is an equity stock that focuses on the biotechnology and pharmaceutical sector. The fund does not currently maintain a dividend distribution program, making it unsuitable for income-focused investors seeking regular dividend payments. This holding appeals primarily to growth-oriented investors seeking exposure to the therapeutic development space rather than those prioritizing current yield.

ADCT key facts

Asset type
Stock
Asset class
Equity
Inception date
05/15/2020
Last close
$1.01
Market cap
$171,708,064
Average volume
1347088.0
Beta
1.877
Payout ratio
0.0
Forward P/E
0.0
EPS
$-0.97